Gamma-aminobutyric acid type A receptor β3 subunit forebrain-specific knockout mice are resistant to the amnestic effect of isoflurane. 2011

Vinuta Rau, and Irene Oh, and Mark Liao, and Christina Bodarky, and Michael S Fanselow, and Gregg E Homanics, and James M Sonner, and Edmond I Eger
Department of Anesthesia, S-455, University of California San Francisco, San Francisco, CA 94143-0464, USA. vinutarau@yahoo.com

BACKGROUND β3 containing γ-aminobutyric acid type A receptors (GABA(A)-Rs) mediate behavioral end points of IV anesthetics such as immobility and hypnosis. A knockout mouse with targeted forebrain deletion of the β3 subunit of the GABA(A)-R shows reduced sensitivity to the hypnotic effect of etomidate, as measured by the loss of righting reflex. The end points of amnesia and immobility produced by an inhaled anesthetic have yet to be evaluated in this conditional knockout. METHODS We assessed forebrain selective β3 conditional knockout mice and their littermate controls for conditional fear to evaluate amnesia and MAC, the minimum alveolar concentration of inhaled anesthetic necessary to produce immobility in response to noxious stimulation, to assess immobility. Suppression of conditional fear was assessed for etomidate and isoflurane, and MAC was assessed for isoflurane. RESULTS Etomidate equally suppressed conditional fear for both genotypes. The knockout showed resistance to the suppression of conditional fear produced by isoflurane in comparison with control littermates. Controls and knockouts did not differ in isoflurane MAC values. CONCLUSIONS These results suggest that β3 containing GABA(A)-Rs in the forebrain contribute to hippocampal-dependent memory suppressed by isoflurane, but not etomidate.

UI MeSH Term Description Entries
D007530 Isoflurane A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010147 Pain Measurement Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies. Analgesia Tests,Analogue Pain Scale,Formalin Test,McGill Pain Questionnaire,Nociception Tests,Pain Assessment,Pain Intensity,Pain Severity,Tourniquet Pain Test,Visual Analogue Pain Scale,Analog Pain Scale,Assessment, Pain,McGill Pain Scale,Visual Analog Pain Scale,Analgesia Test,Analog Pain Scales,Analogue Pain Scales,Formalin Tests,Intensity, Pain,Measurement, Pain,Nociception Test,Pain Assessments,Pain Intensities,Pain Measurements,Pain Questionnaire, McGill,Pain Scale, Analog,Pain Scale, Analogue,Pain Scale, McGill,Pain Severities,Pain Test, Tourniquet,Questionnaire, McGill Pain,Scale, Analog Pain,Scale, Analogue Pain,Scale, McGill Pain,Severity, Pain,Test, Analgesia,Test, Formalin,Test, Nociception,Test, Tourniquet Pain,Tests, Nociception,Tourniquet Pain Tests
D011963 Receptors, GABA-A Cell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and contain an integral membrane chloride channel. Each receptor is assembled as a pentamer from a pool of at least 19 different possible subunits. The receptors belong to a superfamily that share a common CYSTEINE loop. Benzodiazepine-Gaba Receptors,GABA-A Receptors,Receptors, Benzodiazepine,Receptors, Benzodiazepine-GABA,Receptors, Diazepam,Receptors, GABA-Benzodiazepine,Receptors, Muscimol,Benzodiazepine Receptor,Benzodiazepine Receptors,Benzodiazepine-GABA Receptor,Diazepam Receptor,Diazepam Receptors,GABA(A) Receptor,GABA-A Receptor,GABA-A Receptor alpha Subunit,GABA-A Receptor beta Subunit,GABA-A Receptor delta Subunit,GABA-A Receptor epsilon Subunit,GABA-A Receptor gamma Subunit,GABA-A Receptor rho Subunit,GABA-Benzodiazepine Receptor,GABA-Benzodiazepine Receptors,Muscimol Receptor,Muscimol Receptors,delta Subunit, GABA-A Receptor,epsilon Subunit, GABA-A Receptor,gamma-Aminobutyric Acid Subtype A Receptors,Benzodiazepine GABA Receptor,Benzodiazepine Gaba Receptors,GABA A Receptor,GABA A Receptor alpha Subunit,GABA A Receptor beta Subunit,GABA A Receptor delta Subunit,GABA A Receptor epsilon Subunit,GABA A Receptor gamma Subunit,GABA A Receptor rho Subunit,GABA A Receptors,GABA Benzodiazepine Receptor,GABA Benzodiazepine Receptors,Receptor, Benzodiazepine,Receptor, Benzodiazepine-GABA,Receptor, Diazepam,Receptor, GABA-A,Receptor, GABA-Benzodiazepine,Receptor, Muscimol,Receptors, Benzodiazepine GABA,Receptors, GABA A,Receptors, GABA Benzodiazepine,delta Subunit, GABA A Receptor,epsilon Subunit, GABA A Receptor,gamma Aminobutyric Acid Subtype A Receptors
D003213 Conditioning, Psychological Simple form of learning involving the formation, strengthening, or weakening of an association between a stimulus and a response. Conditioning, Psychology,Psychological Conditioning,Social Learning Theory,Social Learning Theories,Theory, Social Learning
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005045 Etomidate Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic. Ethomidate,Hypnomidate,R-26490,Radenarkon,R 26490,R26490
D005239 Fear The affective response to an actual current external danger which subsides with the elimination of the threatening condition. Threat Cues,Threat Sensitivity,Cue, Threat,Fears,Sensitivity, Threat,Threat Cue,Threat Sensitivities
D005260 Female Females

Related Publications

Vinuta Rau, and Irene Oh, and Mark Liao, and Christina Bodarky, and Michael S Fanselow, and Gregg E Homanics, and James M Sonner, and Edmond I Eger
December 2004, The Journal of biological chemistry,
Vinuta Rau, and Irene Oh, and Mark Liao, and Christina Bodarky, and Michael S Fanselow, and Gregg E Homanics, and James M Sonner, and Edmond I Eger
June 2004, Anesthesiology,
Vinuta Rau, and Irene Oh, and Mark Liao, and Christina Bodarky, and Michael S Fanselow, and Gregg E Homanics, and James M Sonner, and Edmond I Eger
August 1999, Proceedings of the National Academy of Sciences of the United States of America,
Vinuta Rau, and Irene Oh, and Mark Liao, and Christina Bodarky, and Michael S Fanselow, and Gregg E Homanics, and James M Sonner, and Edmond I Eger
February 1992, Proceedings of the National Academy of Sciences of the United States of America,
Vinuta Rau, and Irene Oh, and Mark Liao, and Christina Bodarky, and Michael S Fanselow, and Gregg E Homanics, and James M Sonner, and Edmond I Eger
March 2005, The Journal of clinical investigation,
Vinuta Rau, and Irene Oh, and Mark Liao, and Christina Bodarky, and Michael S Fanselow, and Gregg E Homanics, and James M Sonner, and Edmond I Eger
April 2006, The Journal of comparative neurology,
Vinuta Rau, and Irene Oh, and Mark Liao, and Christina Bodarky, and Michael S Fanselow, and Gregg E Homanics, and James M Sonner, and Edmond I Eger
July 2006, Anesthesiology,
Vinuta Rau, and Irene Oh, and Mark Liao, and Christina Bodarky, and Michael S Fanselow, and Gregg E Homanics, and James M Sonner, and Edmond I Eger
June 2007, Neuroscience letters,
Vinuta Rau, and Irene Oh, and Mark Liao, and Christina Bodarky, and Michael S Fanselow, and Gregg E Homanics, and James M Sonner, and Edmond I Eger
March 1998, Anesthesiology,
Vinuta Rau, and Irene Oh, and Mark Liao, and Christina Bodarky, and Michael S Fanselow, and Gregg E Homanics, and James M Sonner, and Edmond I Eger
April 1997, Molecular pharmacology,
Copied contents to your clipboard!